JPS5813523A - 抗腫瘍作用を有する医薬組成物 - Google Patents

抗腫瘍作用を有する医薬組成物

Info

Publication number
JPS5813523A
JPS5813523A JP56112856A JP11285681A JPS5813523A JP S5813523 A JPS5813523 A JP S5813523A JP 56112856 A JP56112856 A JP 56112856A JP 11285681 A JP11285681 A JP 11285681A JP S5813523 A JPS5813523 A JP S5813523A
Authority
JP
Japan
Prior art keywords
acidic protease
acidic
medicinal composition
antitumor action
antitumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56112856A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6237614B2 (enrdf_load_stackoverflow
Inventor
Haruo Onishi
治夫 大西
Koji Kojiyaku
小雀　浩司
Yasuo Suzuki
泰雄 鈴木
Suguru Mochida
持田　英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Priority to JP56112856A priority Critical patent/JPS5813523A/ja
Priority to CA000395742A priority patent/CA1181005A/en
Priority to SE8200748A priority patent/SE455163B/sv
Priority to GB8203682A priority patent/GB2095993B/en
Priority to CH782/82A priority patent/CH653557A5/de
Priority to AU80290/82A priority patent/AU531314B2/en
Priority to FR8202145A priority patent/FR2499409A1/fr
Priority to DE19823204631 priority patent/DE3204631A1/de
Priority to IT47761/82A priority patent/IT1154280B/it
Priority to EP82100973A priority patent/EP0059346B1/en
Priority to DE8282100973T priority patent/DE3273953D1/de
Priority to NL8200509A priority patent/NL8200509A/nl
Priority to US06/365,465 priority patent/US4540569A/en
Publication of JPS5813523A publication Critical patent/JPS5813523A/ja
Publication of JPS6237614B2 publication Critical patent/JPS6237614B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP56112856A 1981-02-10 1981-07-18 抗腫瘍作用を有する医薬組成物 Granted JPS5813523A (ja)

Priority Applications (13)

Application Number Priority Date Filing Date Title
JP56112856A JPS5813523A (ja) 1981-07-18 1981-07-18 抗腫瘍作用を有する医薬組成物
CA000395742A CA1181005A (en) 1981-02-10 1982-02-08 Therapeutic agent for treatment of allergic diseases, immune complex diseases and tumors
SE8200748A SE455163B (sv) 1981-02-10 1982-02-09 Uropepsin for anvendning som terapeutikum mot allergiska sjukdomar, immunkomplexsjukdomar och tumorer
GB8203682A GB2095993B (en) 1981-02-10 1982-02-09 Compositions containing human urinary acid protease
CH782/82A CH653557A5 (de) 1981-02-10 1982-02-09 Zur behandlung von allergischen zustaenden, immunkomplexkrankheiten und tumoren geeignetes therapeutisches mittel.
AU80290/82A AU531314B2 (en) 1981-02-10 1982-02-09 Therapeutic agent containing human urinary acid protease
FR8202145A FR2499409A1 (fr) 1981-02-10 1982-02-10 Agent therapeutique a base d'une protease acide, pour le traitement des troubles allergiques, des maladies avec immunocomplexe et des tumeurs
DE19823204631 DE3204631A1 (de) 1981-02-10 1982-02-10 Therapeutisches mittel und dessen verwendung
IT47761/82A IT1154280B (it) 1981-02-10 1982-02-10 Agente terapeutico a base di protea si acida e suo impiego in pazienti affetti da disordini allergici,malattie da immuno-complessi e tumori
EP82100973A EP0059346B1 (en) 1981-02-10 1982-02-10 Therapeutic agent containing a human urinary pepsin
DE8282100973T DE3273953D1 (en) 1981-02-10 1982-02-10 Therapeutic agent containing a human urinary pepsin
NL8200509A NL8200509A (nl) 1981-02-10 1982-02-10 Geneesmiddel voor allergiekwalen, immuuncomplexziekten en tumoren; werkwijze voor het behandelen van patienten die hieraan lijden.
US06/365,465 US4540569A (en) 1981-02-10 1982-04-05 Method for treatment of allergic disorders and immune complex diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56112856A JPS5813523A (ja) 1981-07-18 1981-07-18 抗腫瘍作用を有する医薬組成物

Publications (2)

Publication Number Publication Date
JPS5813523A true JPS5813523A (ja) 1983-01-26
JPS6237614B2 JPS6237614B2 (enrdf_load_stackoverflow) 1987-08-13

Family

ID=14597240

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56112856A Granted JPS5813523A (ja) 1981-02-10 1981-07-18 抗腫瘍作用を有する医薬組成物

Country Status (1)

Country Link
JP (1) JPS5813523A (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6261926A (ja) * 1985-09-13 1987-03-18 Hiroshi Maeda 制癌剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6261926A (ja) * 1985-09-13 1987-03-18 Hiroshi Maeda 制癌剤

Also Published As

Publication number Publication date
JPS6237614B2 (enrdf_load_stackoverflow) 1987-08-13

Similar Documents

Publication Publication Date Title
Spiers et al. Hairy-cell leukemia: induction of complete remission with pentostatin (2'-deoxycoformycin).
KR950014915B1 (ko) 탈시알로당단백-포함화합물
HU227992B1 (en) Interferon conjugates, process for prepairing them, pharmaceutical compositions, containing them and use of them
EP3773686B1 (en) Alkaline phosphatase agents for treatment of radiation disorders
US5565431A (en) Cancer cell inhibitors and method
US6720011B1 (en) Injectable composition for cancer treatment
Pinkel et al. Radiotherapy in leukemia and lymphoma of children
RU2335539C2 (ru) Фармацевтический препарат и способ лечения злокачественных опухолей у человека с помощью аргининовой депривации
JPS61155324A (ja) 癌治療薬剤
CN101591649B (zh) 甲氧基聚乙二醇修饰的精氨酸脱亚氨酶及其制备与应用
JPS5813523A (ja) 抗腫瘍作用を有する医薬組成物
US10865403B2 (en) Engineered primate cystine/cysteine degrading enzymes for therapeutic uses
AU2004244755B2 (en) Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds
Hanauer et al. Long-term follow-up of patients treated with infliximab (anti-TNFA antibody) in clinical trials
JP2020537689A (ja) Ａ−ノル−５αアンドロスタン化合物を含む白血球増多製剤およびその使用
Ohkoshi et al. Clinical experience with a protease inhibitor [N, N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate for prevention of recurrence of carcinoma of the mouth and in treatment of terminal carcinoma
CA1329541C (en) Pharmaceutical composition for relieving side effects of platinum-containing drugs
NL8200509A (nl) Geneesmiddel voor allergiekwalen, immuuncomplexziekten en tumoren; werkwijze voor het behandelen van patienten die hieraan lijden.
EP0100366A1 (en) Agent for treating allergic disease, immunity complex disease, and tumour
JPS5995221A (ja) 食細胞機能調節作用を有する医薬組成物
CN114028544B (zh) 一种动员淋巴瘤和骨髓瘤干细胞的药物组合物
JPH07504202A (ja) ロイキンフェロン製剤
EP0753309A2 (en) Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases
RU2026679C1 (ru) Способ противоопухолевой терапии при первичном раке печени
Dejaco et al. Safety and efficacy of granulocyte colony stimulating factor (G-CSF) for treatment of severe endoscopic postoperative recurrence in Crohn's disease (CD)